Clinical Trial Update: A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating oral ARD-101 in patients with Prader-Willi Syndrome has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prader-willi Syndrome

Drugs mentioned

• ARD-101

Snippet

Sponsor: Aardvark Therapeutics, Inc. | Conditions: Prader-Willi Syndrome | Phase 2 | Status: COMPLETED